Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 13
410
Views
8
CrossRef citations to date
0
Altmetric
Review

Total alkaloids from the rhizomes of Ligusticum striatum: a review of chemical analysis and pharmacological activities

, , &
Pages 3489-3506 | Received 12 Jul 2020, Accepted 13 Sep 2020, Published online: 09 Oct 2020

References

  • Cai X, Chen Z, Pan X, Xia L, Chen P, Yang Y, Hu H, Zhang J, Li K, Ge J, et al. 2014. Inhibition of angiogenesis, fibrosis and thrombosis by tetramethylpyrazine: mechanisms contributing to the SDF-1/CXCR4 axis. PLoS One. 9(2):e88176.
  • Cao Y, Wang TJ, Wang Y, Yang Z, Bi KS. 2005. HPLC Determination of tetramethylpyrazine in Ligusticum chuanxiong Hort. Chin J Pharm Anal. 30:278–280.
  • Chang XL, Jiang ZY, Ma YB, Zhang XM, Tsim KW, Chen JJ. 2009. Two new compounds from the roots of Ligusticum chuanxiong. J Asian Nat Prod Res. 11(9):805–810.
  • Chen L, Liu T, Wang Q, Liu J. 2017. Anti-inflammatory effect of combined tetramethylpyrazine, resveratrol and curcumin in vivo. BMC Complement Altern Med. 17(1):233.
  • Chen L, Lu Y, Wu JM, Xu B, Zhang LJ, Gao M, Zheng SZ, Wang AY, Zhang CB, Zhang WW, et al. 2009. Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by Vascular Endothelial Growth Factor. Biochem Biophys Res Commun. 386(2):374–379.
  • Chen Y, Yang X, Han FM, Chen ZY. 1999. Determination of Ligustrazin and ferulic acidin Chuangxiong rhizome by capillary electrophoresis. Acta Pharm Sin. 34:699–701.
  • Chen ZJ, Zhang C, Gao F, Fu Q, Fu CM, He Y, Zhang JM. 2018. A systematic review on the rhizome of Ligusticum chuanxiong Hort. (Chuanxiong). Food Chem Toxicol. 119:309–325.
  • Cui XY, Liu HM. 2009. Experimental study of Chuanxiong alkaloids against isoprenaline-induced acute myocardial ischemia. Chin J Ctrl Endem Dis. 24:61.
  • Dai L. 2009. Study on ultrafine vibration extraction technology of Rhizoma Chuanxiong. China J Chin Mat Med. 34:977–979.
  • Dai XZ, Bache RJ. 1985. Coronary and systemic haemodynamic effect of tetramethylpyrazine in the dog. J Cardiovasc Pharmacol. 7:841–849.
  • Frangogiannis NG. 2014. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 11(5):255–265.
  • Gao J, Qu XF, Liu Y, Wang LY. 2009. Effect of Chuanxiong alkaloids on SOD, MDA, nerve function and cerebral infarction volume in rats with cerebral ischemia-reperfusion. Chin J Gerontol. 29:22–24.
  • Guan D, Su Y, Li Y, Wu C, Meng Y, Peng X, Cui Y. 2015. Tetramethylpyrazine inhibits CoCl2 -induced neurotoxicity through enhancement of Nrf2/GCLc/GSH and suppression of HIF1α/NOX2/ROS pathways. J Neurochem. 134(3):551–565.
  • Guo M, Liu Y, Shi DZ. 2016. Cardiovascular actions and therapeutic potential of tetramethylpyrazine (Active component isolated from Rhizoma Chuanxiong): Roles and Mechanisms). Biomed Res Int. 2016:2430329.
  • Hanh TT, Anh DH, Huong PH, Thanh NV, Trung NQ, Cuong TV, Mai NT, Cuong NT, Cuong NX, Nam NH, et al. 2018. Crinane, augustamine, and β-carboline alkaloids from Crinum latifolium. Phytochem Lett. 24:27–30.
  • He ZY, Liu Y, Jia MR, Qiang Y, Ma YY, Chen K, Zhang Y, Jiang G. 2004. Determination of the total alkaloids contents from Ligusticum chuanxiong (Naichuanxiong, Shanchuanxiong and Rhizoma chuanxiong). West China J Pharm Sci. 19:292–293.
  • Heitzer T, Schlinzig T, Krohn K, Meinertz T, MüNzel T. 2001. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 104(22):2673–2678.
  • Hong YL, Jin YQ, Yao YX, Lin MY, Wei BP, Jiang WD, Lv GH. 2015. Assay of Tetramethylpyrazine in Szechwan Lovage Rhizome and Cnidium Rhizome by HPLC-DAD-MS. Chin Med Mater. 38:36–40.
  • Hong YL. 2015. Comparison study on alkaloid and anti-blood agglomeration between Chinese Chuanxiong and Japanese Chuanxiong. Chengdu: Chengdu University of TCM China 26.
  • Hu J, Jia X, Fang X, Li P, He C, Chen M. 2016. Ultrasonic extraction, antioxidant and anticancer activities of novel polysaccharides from Chuanxiong rhizome. Int J Biol Macromol. 85:277–284.
  • Ji YF, Liu HX. 2011. Effect of Chuanxiong alkaloid on SOD activity, NO, NOS and MDA content in rat brain. Chin Med Mod Dis Educ. 9:212–213.
  • Jia Y, Wang Z, Zang A, Jiao S, Chen S, Fu Y. 2016. Tetramethylpyrazine inhibits tumor growth of lung cancer through disrupting angiogenesis via BMP/Smad/Id-1 signaling. Int J Oncol. 48(5):2079–2086.
  • Kim M, Kim SO, Lee M, Lee JH, Jung WS, Moon SK, Kim YS, Cho KH, Ko CN, Lee EH. 2014. Tetramethylpyrazine, a natural alkaloid, attenuates pro-inflammatory mediators induced by amyloid β and interferon-γ in rat brain microglia. Eur J Pharmacol. 740:504–511.
  • Lee SH, Jeong SJ, Jang GY, Kim MY, Hwang IG, Kim HY, Woo KS, Hwang BY, Song J, Lee J, Jeong HS. 2016. Isolation and identification of an antiproliferative compound from fructose-tryptophan maillard reaction products. J Agric Food Chem. 64(15):3041–3047.
  • Lei ZD, Lei ZJ, Dai L. 2011. Simultaneous determination of the content of Ligustazine and Ferulic acid in Cuidium officiuale by HPLC. Chin Her Med. 8:57–59.
  • Li HB, Chen F. 2004. Preparative isolation and purification of chuanxiongzine from the medicinal plant Ligusticum chuanxiong by high-speed counter-current chromatography. J Chromatogr A. 1047(2):249–253.
  • Li HX, Ding MY, Lü K, Yu JY. 2001. Determination of the active ingredients in Chuanxiong by HPLC, HPLC-MS, and EI-MS. J. Liq. Chrom Rel Technol. 24:2017–2031.
  • Li J, Yu J, Ma H, Yang N, Li L, Zheng DD, Wu MX, Zhao ZL, Qi HY. 2017. Intranasal pretreatment with Z-Ligustilide, the main volatile component of Rhizoma Chuanxiong, confers prophylaxis against cerebral ischemia via Nrf2 and HSP70 signaling pathways. J Agric Food Chem. 65(8):1533–1542.
  • Li JH, Cao XP, Wei JJ, Song L, Liao FJ, Zheng GQ, Lin Y. 2015. Chuanxiong chadiao powder, a famous Chinese herbal prescription, for headache: A systematic review and meta-analysis. Complement Ther Med. 23(4):577–590.
  • Li M, Handa S, Ikeda Y, Goto S. 2001. Specific inhibiting characteristics of tetramethylpyrazine, one of the active ingredients of the Chinese herbal medicine 'Chuanxiong,' on platelet thrombus formation under high shear rates. Thromb Res. 104(1):15–28.
  • Li S, Li J, Guan XL, Li J, Deng SP, Li LQ, Tang MT, Huang JG, Chen ZZ, Yang RY. 2011. Hypoglycemic effects and constituents of the barks of Cyclocarya paliurus and their inhibiting activities to glucosidase and glycogen phosphorylase. Fitoterapia. 82(7):1081–1085.
  • Li SL. 2001. Determination of alkaloid content in different processed products of Chuanxiong. J. Henan Coll. Tradit Chin Med. 16:18–19.
  • Li W, Tang Y, Chen Y, Duan JA. 2012. Advances in the chemical analysis and biological activities of Chuanxiong. Molecules. 17(9):10614–10651.
  • Li WM, Liu HT, Li XY, Wu JY, Xu G, Teng YZ, Ding ST, Yu C. 2010. The effect of tetramethylpyrazine on hydrogen peroxide-induced oxidative damage in human umbilical vein endothelial cells. Basic Clin Pharmacol Toxicol. 106:45–52.
  • Li XY, Guan YT, Huang AB, Liang XF, Lei FH. 2009. Study on optimum ultrasonic extraction process of ligustrazine hydrochloride from Ligusticum chuanxiong Hort. by orthogonal design. Lishizhen Med Mat Med Res. 20:1990–1992.
  • Li XY, He JL, Liu HT, Li WM, Yu C. 2009. Tetramethylpyrazine suppresses interleukin-8 expression in LPSstimulated human umbilical vein endothelial cell by blocking ERK, p38 and nulear factor-kappaB signaling pathways. J Ethnopharmacol. 125(1):83–89.
  • Li YQ, Zhou NQ, Wang R, Yu HL, Zou SY. 2016. The extraction and determination methods of ferulic acid and ligustrazine in Ligusticum Chuanxiong Hort. J Anhui Norm Univ. 39:55–59.
  • Liang YC, Guo H, Liu SJ, Liu YP, Chen Hp, Chen L. 2018. Determination of 7 components in Ligusticum chuanxiong Hort. by one measurement and multiple evaluation. Chin Med Mater. 41:140–143.
  • Lisztes E, Tóth BI, Bertolini M, Szabó IL, Zákány N, Oláh A, Szöllősi AG, Paus R, Bíró T. 2020. Adenosine promotes human hair growth and inhibits catagen transition In Vitro: Role of the Outer Root Sheath Keratinocytes. J Invest Dermatol. 140(5):1085–1088.e6.
  • Liu J, Pu ZH, Peng C, Zhang X, Li WB, Dai O. 2018. Inhibition effect of total alkaloid, total phenolic acid and total volatile oil from Ligusticum chuanxiong on the contraction of isolated uterine smooth muscle of rats. J China Pharm. 29:621–624.
  • Liu X, Jiang MW, Wang LY, Shen XP. 2016. Protective effect of Chuanxiong alkaloid on cerebral ischemia reperfusion injury in rats. J Beihua Univ. 17:339–343.
  • Liu X, Zhao Q, Li C, Zhang R, Wang X, Xu W. 2003. Synthesis of Chuanxiong perlolyrine and its protective effect on injured vascular endothelial cells. J Shandong Univ. 5:485–487.
  • Liu YY, Zhang L, Cai GY, Xing Q, Wang X, Yin H. 2016. Simultaneous determination of ligustilide, tetramethylpyrazine, α-Asarone in Chuanxiong gas chromatography. Chin J Tradit Chin Med Pharm. 34:2461–2463.
  • Lv L, Jiang SS, Xu J, Gong JB, Cheng Y. 2012. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthas. Clin Exp Pharmacol Physiol. 39(1):20–27.
  • Ma L, Wang XJ, Zhang J, Zhao QD, Chen ZJ. 2007. Explore the best extractive craft of tetramethylpyrazine from Rhizoma Chuanxiong. Lishizhen Med Mat Med Res. 18:3057–3058.
  • Ma LN, Bai M, Wang JY, Shi YJ. Wang Cl 2013. Optimization of extraction technology for total alkaloids from Ligusticum chuanxiong by central composite design/response surface methodology. Cent South Pharm. 11:96–98.
  • Ma XQ, Feng WK, Xin D, Guo P. 2020. Study Progress on effect of ligustrazine on cardio-cerebrovascular diseases and the underlying mechanism. J Shandong TCM. 39:530–533.
  • Mei JJ, Cai DY, Zhao TX, Tian WH, Ye GM, Chen ZF, Qiao M, Zhou AF, Zhao G. 2000. Study on Chuanxiong regulating the effective parts of rabbit hyperlipidemia. Chin J Micro Chin J Micro. 10:51.
  • Nakatsuka SI, Feng BN, Goto T, Kihara K. 1986. Structures of flazin and YS, highly fluorescent compounds isolated from japanese soy sauce. Tetrahedron Lett. 27(29):3399–3402.
  • Oshida M, Matsuura Y, Hotta S, Watanabe J, Mogi Y, Watanabe T. 2017. Isolation and identification of a humanTRPV1 activating compound from soy sauce. Biosci Biotechnol Biochem. 81(5):987–994.
  • Ou Y, Guo XL, Zhai L, Liu XY, Cheng YN. 2010. TMPDP, a tetramethylpyrazine derivative, protects vascular endothelial cells from oxidation damage by hydrogen peroxide. Pharmazie. 65(10):755–759.
  • Peng C, Liu YP, Chen HP, Xiang CB. 2011. Discussion on forming pattern of Dao-di Herbs Ligusticum chuanxiong. China J Chin Mat Med. 36:2303–2305.
  • Pu ZH, Dai M, Peng C, Xiong L. 2020. Research progress on the material basis and pharmacological effects of the alkaloids from from the rhizomes of Ligusticum striatum. J China Pharm. 31:1020–1024.
  • Pu ZH, Liu J, Peng C, Luo M, Zhou QM, Xie XF, Chen MH, Xiong L. 2019a. Nucleoside alkaloids with anti-platelet aggregation activity from the rhizomes of Ligusticum striatum. Nat Prod Res. 33(10):1399–1405.
  • Pu ZH, Meng CW, Zhou YX, Peng C, Du JC, Xiong L. 2016. Study on chemical constituents of Ligusticum chuanxiong. J Chin Med Mater. 39:2531–2533.
  • Pu ZH, Peng C, Xie XF, Luo M, Zhu H, Feng R, Xiong L. 2019b. Alkaloids from the Rhizomes of Ligusticum striatum exert antimigraine effects through regulating 5-HT1B receptor and c-Jun. J Ethnopharmacol. 237:39–46.
  • Pu ZH, Su HG, Wang L, Liu LS, Peng C, LW, Xiong L. 2017a. Optimization of extraction technology of total alkaloids from Ligusticum chuanxiong Hort. by orthogonal test. J Chengdu Univ TCM. 40:20–24.
  • Pu ZH, Wang L, Gao Y, Zhang X, Peng C, Xiong L, Li WB. 2017b. Purification and enrichment of total alkaloids from Ligusticum chuanxiong Hort. by macroporous resin. Food Res Dev. 38:85–89.
  • Ran X, Ma L, Peng C, Zhang H, Qin LP. 2011. Ligusticum chuanxiong Hort: A review of chemistry and pharmacology. Pharm Biol. 49(11):1180–1189.
  • Ren ZQ, Ma JH, Zhang PH, Luo AT, Zhang S, Kong LH, Qian CP. 2012. The effect of ligustrazine on L-type calcium current, calcium transient and contractility in rabbit ventricular myocytes. J Ethnopharmacol. 144(3):555–561.
  • Sheu JR, Hsiao G, Luk HN, Chen YW, Chen TL, Lee LW, Lin CH, Chou DS. 2002. Mechanisms involved in the antiplatelet activity of midazolam in human platelets. Anesthesiology. 96(3):651–658.
  • Sun XG, Wang T, Zhu JS. 2001. Determination of Tetramethylpyrazine in Ligusticum Chuanxiong Hort by RP-HPLC coupled with countercurrent extraction. Acta Univ Med Tongji. 30:209–210.
  • Tang G, Jiang GH, Wang SZ, Zheng LF. 2001. Inhibitory effect on platelet aggregation and antithrombotic effect of perlolyrine and its analogues. Chin J Pharmacol Toxicol. 15:317–329.
  • Tibaut M, Mekis D, Petrovic D. 2017. Pathophysiology of myocardial infarction and acute management strategies. Cardiovasc Hematol Agents Med Chem. 14(3):150–159.
  • Tsai CC, Lai TY, Huang WC, Yang T, Liu IM, Wong KL, Chan P, Cheng JT. 2003. Tetramethylpyrazine as potassium channel opener to lower calcium influx into cultured aortic smooth muscle cells. Planta Med. 69(6):557–558.
  • Wang F, Zhu K, You WM. 2008. Study on extraction technology of tetramethylpyrazine in Ligusticum chuanxiong Hort. by supercritical CO2 extraction. Chin Pharm. 17:42–43.
  • Wang JC, Liu W, Yang RL, Sun XB. 2014. Influence of Chuanxiong polysaccharide on proliferation and apoptosis of human hepatoma cell HepG2. J Nanjing Univ Chin Med. 30:461–464.
  • Wang LY, Duan DH, Yang GQ. 2006. Influences of the bioalkali ingredients of Chuanxiong on nitrogen nonoxide,nitrocoxide synthase in the serum of focal cerebral ischemia-reperfusion. J Beihua Univ. 7:138–140.
  • Wang LY, Qu X, Liu X, Huiang XL, Cui XY. 2008. Effect of Chuanxiong alkaloid on SOD activity, NO, NOS and MDA content in rat serum. Chin J Gerontol. 28:1989–1990.
  • Wang Q, Shen L, Liang S, Ma SY, Feng Y, Ruan KF. 2015. Effects of Ligusticum chuanxiong on plasma and brain pharmacokinetics of active ingredients from Gastrodia elata in migraine rats. Chin Trad Pat Med. 37:62–69.
  • Wang SB, Song HG. 2009. Colorimetric determination of total alkaloids in Ligusticum chuanxiong with reinecke salt. Cent South Pharm. 7:824–826.
  • Wei W, Xu W, Yang XW. 2017. Two new phthalide dimers from the rhizomes of Ligusticum chuanxiong. J Asian Nat Prod Res. 19(7):704–711.
  • Xu PB, Tian L, Xu B, He P, Li LF. 2001. Assay of ligustrazine by high performance capillary electrophoresis. Chin JM AP. 18:383–385.
  • Yang H, Liu L, Zhang HJ. 2009. Study for the extraction process and quality standards of tetramethylpyrazine. Chin J Ethnomed Ethnopharm. 4:24.
  • Yang J, Feng XL, Yu Y, Wang Q, Zou J, Wang CX, Mu ZQ, Yao XS, Gao H. 2016. Novel phthalide derivatives identified from Ligusticum chuanxiong (Chuanxiong). Chin Med. 11:10.
  • Yang NY, Ren DC, Duan JA, Xu XH, Xie N, Tian LJ. 2009. Ceramides and cerebrosides from Ligusticum chuanxiong Hort. Helv Chim Acta. 92(2):291–297.
  • Yao ZL, Du SY, Lu Y, Xu B, Chen XL. 2010. Simultaneous determination of five effective components in Rhizoma Chuanxiong by RP-HPLC. Chin J Chin Mater Med. 35:2696–2699.
  • Yuan BY, Yuan H, Zhao M. 2000. Determination of tetramethylpyrazine in three kinds of decoction pieces. Chin Tradit Herbal Drugs. 31:430–431.
  • Yuan XP, Liu LS, Fu Q, Wang CX. 2012. Effects of ligustrazine on ureteral obstruction-induced renal tubulointerstitial fibrosis. Phytother Res. 26(5):697–703.
  • Zhang L, Zhang CF, Xu XH, Zhang M. 2017. A review on the extraction and separation of alkaloids. Asia-Pacific TCM. 13:49–50.
  • Zhang W, Liu JW. 2018. Protective effect of ligusticum alkaloids on rat cardiomyocyte injury. Chin J Ctrl Endem Dis. 33:615–616.
  • Zhao HY. 2010. Optimization of paozhi technology of jiu Ligusticum chuanxiong Hort. by orthogonal testby orthogonal experiment. J Anhui Med Pham. 14:528–529.
  • Zheng HH, Luo DS, Li YH, Wang MJ. 2006. Interference effects of tatramethylpyrazine on the proliferation of vascular smooth muscle cells induced by angiotensin II. Med J Chin People’s Liberation Army. 31:1082–1086.
  • Zhou JS, Kong Y, Shentu XZ, Zheng GY. 2008. Study on Content variation of active in gradient between single and mixed decoction on Ligusticum Chuanxiong and Angelica. Chin Pharm J. 43:95–98.
  • Zhu CF, Shi QX, Yan YP, Liu SW, Sun LY, Liu FJ, Tong LQ. 2008. Determination and Fingerprint Analysis of Tetramethyl pyrazine and Ferulic Acid in Ligusticum chuanxiong. Chin Med Mater. 31:1113–1115.
  • Zhu MX, Huang ZF, Xiao HB, Yi JH. 2011. HPLC determination of tetramethylpyrazine in geo-authentic Ligusticum chuanxiong Hort.of Sichuan province. Chin J Pharm Anal. 31:103–106.
  • Zhuang Z, Wang ZH, Huang YY, Zheng Q, Pan XD. 2020. Protective effect and possible mechanisms of ligustrazine isolated from Ligusticum wallichii on nephropathy in rats with diabetes: A preclinical systematic review and meta-analysis. J Ethnopharmacol. 252:112568.
  • Zou LY, Hao XM, Zhang GQ, Zhang M, Guo JH, Liu TF. 2001. Effect of tetramethyl pyrazine on L-type calcium channel in rat ventricular myocytes. Can J Physiol Pharmacol. 79(7):621–626.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.